BR9601193A - Vacina de múltiplos componentes e processos para preparar e administrar a vacina - Google Patents

Vacina de múltiplos componentes e processos para preparar e administrar a vacina

Info

Publication number
BR9601193A
BR9601193A BR9601193A BR9601193A BR9601193A BR 9601193 A BR9601193 A BR 9601193A BR 9601193 A BR9601193 A BR 9601193A BR 9601193 A BR9601193 A BR 9601193A BR 9601193 A BR9601193 A BR 9601193A
Authority
BR
Brazil
Prior art keywords
vaccine
administering
preparing
processes
component
Prior art date
Application number
BR9601193A
Other languages
English (en)
Inventor
Richard E Parizek
Lonny E Vlieger
Sharon A Bryant
Stuart K Nibbelink
Michael J Mcginley
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23633975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9601193(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9601193A publication Critical patent/BR9601193A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR9601193A 1995-03-29 1996-03-29 Vacina de múltiplos componentes e processos para preparar e administrar a vacina BR9601193A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/412,676 US6743430B1 (en) 1995-03-29 1995-03-29 Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Publications (1)

Publication Number Publication Date
BR9601193A true BR9601193A (pt) 1998-01-06

Family

ID=23633975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9601193A BR9601193A (pt) 1995-03-29 1996-03-29 Vacina de múltiplos componentes e processos para preparar e administrar a vacina

Country Status (11)

Country Link
US (3) US6743430B1 (pt)
EP (1) EP0734731B1 (pt)
AR (1) AR002725A1 (pt)
AU (1) AU708878B2 (pt)
BR (1) BR9601193A (pt)
CA (1) CA2172180C (pt)
DE (1) DE69636001T2 (pt)
ES (1) ES2262147T3 (pt)
HU (1) HUP9600781A3 (pt)
PT (1) PT734731E (pt)
ZA (1) ZA962479B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
FR2768747B1 (fr) * 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
EP0924295A3 (en) * 1997-12-04 2001-05-16 Pfizer Products Inc. DNA encoding neospora dihydrofolate reductase-thymidylate synthase
US20070243212A1 (en) * 2006-03-30 2007-10-18 Embrex, Inc. Methods and compositions for vaccination of poultry
US9827299B2 (en) * 2009-10-09 2017-11-28 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
HUE034251T2 (en) 2009-10-30 2018-02-28 Glaxosmithkline Biologicals Sa Purification of type 5 and type 8 capsular saccharides from Staphylococcus aureus
SG10201602668VA (en) 2011-04-22 2016-05-30 Wyeth Llc Compositions relating to a mutant clostridium difficile toxin and methods thereof
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3925544A (en) 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
SU627611A1 (ru) 1977-09-30 1980-02-05 В.П. Землякова Вакцинный препарат в.п. земл ковой против клостридиозов животных и птиц
ZA803063B (en) 1979-05-31 1981-05-27 Ici Australia Ltd Process
ES2199227T5 (es) * 1993-03-29 2007-12-01 Pfizer Inc. Vacunas clostridiales multicomponente que usan adyuvantes de saponina.
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Also Published As

Publication number Publication date
US6743430B1 (en) 2004-06-01
PT734731E (pt) 2006-07-31
US20100111997A1 (en) 2010-05-06
HUP9600781A2 (en) 1996-12-30
EP0734731A3 (en) 1998-03-11
DE69636001T2 (de) 2006-10-26
CA2172180A1 (en) 1996-09-30
US20040141986A1 (en) 2004-07-22
EP0734731A2 (en) 1996-10-02
AR002725A1 (es) 1998-04-29
DE69636001D1 (de) 2006-05-18
HUP9600781A3 (en) 2002-05-28
EP0734731B1 (en) 2006-04-05
AU708878B2 (en) 1999-08-12
CA2172180C (en) 2012-02-21
HU9600781D0 (en) 1996-05-28
ES2262147T3 (es) 2006-11-16
AU4825996A (en) 1996-10-10
ZA962479B (en) 1996-10-03

Similar Documents

Publication Publication Date Title
EE9900014A (et) Erütromütsiinid ja nende valmistamise protsess
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE69525148D1 (de) Pharmazeutische formulierung
FI971279A (fi) Lääkkeitä
DE69502216D1 (de) Zweikomponenten Abgabesystem
FI952932A0 (fi) Monomeeriset insuliinianalogivalmisteet
DE122005000024I2 (de) Darifenacin enthaltende Pharmazeutische zuberreitungen
FI973243A0 (fi) Uusi farmaseuttinen yhdistelmä
IT233201Y1 (it) Dispositivo a due componenti per la somministrazione di farmaci
FI964061A0 (fi) Hiertomylly
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
BR9105406A (pt) Benzodiazepinonas,compostos,cetonas,processo para a preparacao de compostos,medicamento e uso
PT903339E (pt) Bifenilsulfonilcianamidas processos para a sua preparacao e sua utilizacao como medicamentos
BR9601193A (pt) Vacina de múltiplos componentes e processos para preparar e administrar a vacina
GB9408053D0 (en) Pharmaceutical preparation
ITMI941169A0 (it) Formulazioni farmaceutiche
IT1302969B1 (it) Confezione per sostanze medicinali
FI955605A (fi) Aryloivia lääkkeitä
BR9603124A (pt) Dipeptídeo processo para preparação do mesmo mistura e medicamentos
NO961589D0 (no) Farmasöytiske blandinger
PT1086077E (pt) Novos antiestrogeneos processo para a sua preparacao e sua utilizacao farmaceutica
FI951155A0 (fi) Farmaseuttinen valmiste
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
ATA77096A (de) Pharmazeutische präparation

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/05/2006, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE 15A, ANUIDADE(S).

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2137 DE 20/12/2011.